Correlation Between Cognition Therapeutics and Cassava Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Cassava Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Cassava Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Cassava Sciences, you can compare the effects of market volatilities on Cognition Therapeutics and Cassava Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Cassava Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Cassava Sciences.

Diversification Opportunities for Cognition Therapeutics and Cassava Sciences

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Cognition and Cassava is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Cassava Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cassava Sciences and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Cassava Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cassava Sciences has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Cassava Sciences go up and down completely randomly.

Pair Corralation between Cognition Therapeutics and Cassava Sciences

Given the investment horizon of 90 days Cognition Therapeutics is expected to generate 0.31 times more return on investment than Cassava Sciences. However, Cognition Therapeutics is 3.24 times less risky than Cassava Sciences. It trades about -0.24 of its potential returns per unit of risk. Cassava Sciences is currently generating about -0.2 per unit of risk. If you would invest  57.00  in Cognition Therapeutics on August 30, 2024 and sell it today you would lose (17.00) from holding Cognition Therapeutics or give up 29.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cognition Therapeutics  vs.  Cassava Sciences

 Performance 
       Timeline  
Cognition Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Cassava Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cassava Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Cognition Therapeutics and Cassava Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cognition Therapeutics and Cassava Sciences

The main advantage of trading using opposite Cognition Therapeutics and Cassava Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Cassava Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cassava Sciences will offset losses from the drop in Cassava Sciences' long position.
The idea behind Cognition Therapeutics and Cassava Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world